Rapid detection of extended-spectrum-β-lactamase-producing Enterobacteriaceae from urine samples by use of the ESBL NDP test

Journal of Clinical Microbiology

Volumn 52, Issue 10, 2014, Pages 3701-3706

  Dortet, Laurent ^a,b   Poirel, Laurent ^a,c   Nordmann, Patrice ^a,b,c,d  

^a Associated French National Reference Center for Antibiotic Resistance: Carbapenemase producing Enterobacteriaceae   (France)

^b Centre National Associe Centre de Reference des Resistances Aux Antibiotiqus   (France)

^c UNIVERSITY OF FRIBOURG   (Switzerland)

^d Hopital Cantonal de Fribourg   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE CTX M; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; TAZOBACTAM; BETA LACTAMASE;

ADOLESCENT; AGED; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BETA LACTAMASE GENE; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DOUBLE DISC SUSCEPTIBILITY TEST; EXTENDED SPECTRUM BETA LACTAMASE NDP TEST; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; FRANCE; GENE IDENTIFICATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEWBORN; NONHUMAN; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; URINALYSIS; URINARY TRACT INFECTION; ADULT; CHILD; COMPARATIVE STUDY; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; ENZYMOLOGY; EVALUATION STUDY; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; PROCEDURES; TIME; UNIVERSITY HOSPITAL; URINE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIOLOGICAL TECHNIQUES; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; FRANCE; HOSPITALS, UNIVERSITY; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TIME FACTORS; URINE; YOUNG ADULT;

EID: 84907164424     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01578-14     Document Type: Article

References (22)

1. Schappert SM, Rechtsteiner EA. 2011. Ambulatory medical care utilization estimates for 2007. Vital. Health Stat. 13:1-38.
2. Hooton TM. 2012. Clinical practice. Uncomplicated urinary tract infection. N. Engl. J. Med. 366:1028-1037. http://dx.doi.org/10.1056/NEJMcp1104429.
3. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. 2001. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin. Infect. Dis. 32:1162-1171. http://dx.doi.org/10.1086/319757.
4. Ramphal R, Ambrose PG. 2006. Extended-spectrum β-lactamases and clinical outcomes: current data. Clin. Infect. Dis. 42(Suppl 4):S164-S172. http://dx.doi.org/10.1086/500663.
5. Nordmann P, Dortet L, Poirel L. 2012. Rapid detection of extendedspectrum-β-lactamase-producing Enterobacteriaceae. J. Clin. Microbiol. 50:3016-3022. http://dx.doi.org/10.1128/JCM.00859-12.
6. Pezzlo M, York MK. 2004. Urine cultures, p 1-31. In Isenberg HD (ed), Clinical microbiology procedure handbook. American Society of Microbiology, Washington, DC.
7. Drieux L, Brossier F, Sougakoff W, Jarlier V. 2008. Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae: review and bench guide. Clin. Microbiol. Infect. 14(Suppl 1):90-103.
8. Leclercq R, Cantón R, Brown DFJ, Giske CG, Heisig P, MacGowan AP, Mouton JW, Nordmann P, Rodloff AC, Rossolini GM, Soussy C-J, Steinbakk M, Winstanley TG, Kahlmeter G. 2013. EUCAST expert rules in antimicrobial susceptibility testing. Clin. Microbiol. Infect. 19:141-160. http://dx.doi.org/10.1111/j.1469-0691.2011.03703.x.
9. Bonnin RA, Nordmann P, Poirel L. 2013. Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art. Expert Rev. Anti Infect. Ther. 11:571-583. http://dx.doi.org/10.1586/eri.13.38.
10. Carbonne A, Arnaud I, Maugat S, Marty N, Dumartin C, Bertrand X, Bajolet O, Savey A, Fosse T, Eveillard M, Sénéchal H, Coignard B, Astagneau P, Jarlier V, MDRB Surveillance National Steering Group (BMR-Raisin). 2013. National multidrug-resistant bacteria (MDRB) surveillance in France through the RAISIN network: a 9 year experience. J. Antimicrob. Chemother. 68:954-959. http://dx.doi.org/10.1093/jac/dks464.
11. Nicolas-Chanoine MH, Gruson C, Bialek-Davenet S, Bertrand X, Thomas-Jean F, Bert F, Moyat M, Meiller E, Marcon E, Danchin N, Noussair L, Moreau R, Leflon-Guibout V. 2013. Ten-fold increase (2006-11) in the rate of healthy subjects with extended-spectrum β-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre. J. Antimicrob. Chemother. 68:562-568. http://dx.doi.org/10.1093/jac/dks429.
12. Livermore DM, Warner M, Mushtaq S. 2007. Evaluation of the chromogenic Cica-β-Test for detecting extended-spectrum, AmpC and metallo-β-lactamases. J. Antimicrob. Chemother. 60:1375-1379. http://dx.doi .org/10.1093/jac/dkm374.
13. Renvoisé A, Decré D, Amarsy-Guerle R, Huang TD, Jost C, Podglajen I, Raskine L, Genel N, Bogaerts P, Jarlier V, Arlet G. 2013. Evaluation of the βLacta test, a rapid test detecting resistance to third-generation cephalosporins in clinical strains of Enterobacteriaceae. J. Clin. Microbiol. 51: 4012-4017. http://dx.doi.org/10.1128/JCM.01936-13.
14. Morosini IA, García-Castillo M, Tato M, Gijón D, Valverde A, Ruiz-Garbajosa P, Cantón R. 26 February 2014. Rapid detection of β-lactamase-hydrolyzing extended-spectrum cephalosporins in Enterobacteriaceae by use of the new chromogenic β-Lacta test. J. Clin. Microbiol. http://dx.doi.org/10.1128/JCM.03614-13.
15. Beceiro A, Maharjan S, Gaulton T, Doumith M, Soares NC, Dhanji H, Warner M, Doyle M, Hickey M, Downie G, Bou G, Livermore DM, Woodford N. 2011. False extended-spectrum β-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porins. J. Antimicrob. Chemother. 66:2006-2010. http://dx.doi.org/10.1093/jac/dkr265.
16. Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE. 2010. Fosfomycin for the treatment of multidrug-resistant, including extendedspectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect. Dis. 10:43-50. http://dx.doi.org/10.1016/S1473-3099(09)70325-1.
17. Bazaz R, Chapman AL, Winstanley TG. 2010. Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum-β-lactamase-producing Gram-negative organisms. J. Antimicrob. Chemother. 65:1510-1513. http://dx.doi.org/10 .1093/jac/dkq152.
18. Hawkey PM, Livermore DM. 2012. Carbapenem antibiotics for serious infections. BMJ 344:e3236. http://dx.doi.org/10.1136/bmj.e3236.
19. Schwaber MJ, Carmeli Y. 2007. Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J. Antimicrob. Chemother. 60:913-920. http://dx.doi.org/10.1093/jac/dkm318.
20. Nordmann P, Dortet L, Poirel L. 2012. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis. 18:1503-1507. http://dx.doi.org/10.3201/eid1809.120355.
21. Robert J, Pantel A, Mérens A, Lavigne JP, Nicolas-Chanoine MH, on behalf of ONERBAs Carbapenem Resistance Study Group. 16 June 2014. Incidence rates of carbapenemase-producing Enterobacteriaceae clinical isolates in France: a prospective nationwide study in 2011-12. J. Antimicrob. Chemother. http://dx.doi.org/10.1093/jac/dku208.
22. Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U, Kahlmeter G, Pan A, Petrosillo N, Rodríguez-Baño J, Singh N, Venditti M, Yokoe DS, Cookson B, European Society of Clinical Microbiology. 12 December 2013. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrugresistant Gram-negative bacteria in hospitalized patients. Clin. Microbiol. Infect. http://dx.doi.org/10.1111/1469-0691.12427.